668Immune Checkpoint Inhibitor Related Colitis (ICI-Colitis) in Patients With Preexisting Inflammatory Bowel Disease or Microscopic Colitisdoi:10.14309/01.ajg.0000592208.76815.62Sleiman, JosephShah, RaviWei, WeiFunchain, PaulinePhilpott, JessicaSimons-Linares, Roberto...
S2972A Case of Severe ICI-Colitis WithSuprainfectiondoi:10.14309/01.ajg.0001041256.95524.b9Sebastian S. DobrowUniversity of Chicago Medicine, Chicago, IL;Grace E. KimCenter for Endoscopic Research and Therapeutics (CERT), University of Chicago, Chicago, IL;Bradford Chong...
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert ReviewBackground & aims: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients but also...
ColitisImmune checkpoint inhibitors (ICI) have transformed the management of cancer, producing durable responses in a subset of treated patients across multiple malignancies. Immune-mediated diarrhea and colitis (imDC) occurs in up to 20% of ICI-treated patients. The risk of ICI imDC is dependent ...
FMT appeared to be a safer and effective quick treatment alternative for ICI-C. Large scale study is warranted for further clarification of the role of microbiome in this condition.doi:10.1053/j.gastro.2017.11.075Wang YinghongDuPont Herbert
From ICI to ICU: Ipilimumab and Nivolumab-Induced Immune Checkpoint Inhibitor ColitisDigestive Diseases and Sciences -doi:10.1007/s10620-021-07100-4Wendy ZhouJoseph FryeCamille SoroudiGeorge TriadafilopoulosRani BerrySpringer USDigestive Diseases and Sciences...
S215Prevalence and Treatment of Immune Checkpoint Inhibitor (ICI) Colitis in Patients with Gastrointestinal Malignancy: A Multi-Center Network Studydoi:10.14309/01.ajg.0000950500.33845.d9Nikolas NaleidCase Western Reserve University / University Hospitals, Cleveland, OH;Jaime A. Perez...
S218Prevalence and Outcomes of Immune Checkpoint Inhibitor (ICI) Associated Colitis: A Population-Based Cohort Studydoi:10.14309/01.ajg.0000857512.69949.fcNahel A. TunioAakash DesaiShaman DalalMichael KurinNisheet WaghrayWolters KluwerThe American Journal of Gastroenterology...
P103 ROLE OF INFLIXIMAB IN THE MANAGEMENT OF IMMUNE-CHECKPOINT INHIBITORS-MEDIATED COLITIS (ICI-C)doi:10.1053/j.gastro.2017.11.281Wang YinghongDiab AdiAli NomanAbu-Sbeih HamzahJohnson DanielLum PhillipMa JunshengShuttlesworth GladisTrinh Van Anh...
S1969Treatment of Refractory ICI-Associated Colitis With Fecal Microbiota Transplantdoi:10.14309/01.ajg.0000864516.10878.87A. MathewYinghong WangAmerican Journal of Gastroenterology